WO2007054269A3 - Extrakte aus der rinde von corynanthe-arten und deren verwendung sowie diese extrakte enthaltende arzneimittel, diätetische lebensmittel und pharmazeutische zubereitungen - Google Patents

Extrakte aus der rinde von corynanthe-arten und deren verwendung sowie diese extrakte enthaltende arzneimittel, diätetische lebensmittel und pharmazeutische zubereitungen Download PDF

Info

Publication number
WO2007054269A3
WO2007054269A3 PCT/EP2006/010663 EP2006010663W WO2007054269A3 WO 2007054269 A3 WO2007054269 A3 WO 2007054269A3 EP 2006010663 W EP2006010663 W EP 2006010663W WO 2007054269 A3 WO2007054269 A3 WO 2007054269A3
Authority
WO
WIPO (PCT)
Prior art keywords
extracts
bark
medicaments
pharmaceutical preparations
preparations containing
Prior art date
Application number
PCT/EP2006/010663
Other languages
English (en)
French (fr)
Other versions
WO2007054269A2 (de
Inventor
Egon Koch
Hermann Hauer
Original Assignee
Schwabe Willmar Gmbh & Co
Egon Koch
Hermann Hauer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schwabe Willmar Gmbh & Co, Egon Koch, Hermann Hauer filed Critical Schwabe Willmar Gmbh & Co
Priority to AU2006312678A priority Critical patent/AU2006312678B2/en
Priority to US12/084,745 priority patent/US20090142428A1/en
Priority to BRPI0618634-3A priority patent/BRPI0618634A2/pt
Priority to CA002624703A priority patent/CA2624703A1/en
Priority to KR1020087013748A priority patent/KR101306599B1/ko
Priority to JP2008539325A priority patent/JP5435951B2/ja
Priority to EP06818406A priority patent/EP1945238A2/de
Publication of WO2007054269A2 publication Critical patent/WO2007054269A2/de
Publication of WO2007054269A3 publication Critical patent/WO2007054269A3/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Anesthesiology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Die Erfindung betrifft Extrakte aus der Rinde von Corynanthe-Arten, insbesondere von Corynanthe pachyceras, sowie deren Verwendung zur Therapie und Prophylaxe von Erkrankungen der ableitenden Harnwege, von Sexualstörungen, von Fettstoffwechselstörungen, von Herz-Kreislauf-Erkrankungen und von akuten und chronischen Schmerzzuständen. Die Erfindung betrifft ferner diese Extrakte enthaltende Arzneimittel, diätetische Lebensmittel und pharmazeutische Zubereitungen.
PCT/EP2006/010663 2005-11-08 2006-11-07 Extrakte aus der rinde von corynanthe-arten und deren verwendung sowie diese extrakte enthaltende arzneimittel, diätetische lebensmittel und pharmazeutische zubereitungen WO2007054269A2 (de)

Priority Applications (7)

Application Number Priority Date Filing Date Title
AU2006312678A AU2006312678B2 (en) 2005-11-08 2006-11-07 Extracts from the bark of corynanthe species, use thereof, and medicaments, dietary products, and pharmaceutical preparations containing said extracts
US12/084,745 US20090142428A1 (en) 2005-11-08 2006-11-07 Extracts from the Bark of Corynanthe Species and Use Thereof as Well as Medicaments, Dietetic Food Products and Pharmaceutical Preparations Containing Said Extracts
BRPI0618634-3A BRPI0618634A2 (pt) 2005-11-08 2006-11-07 extrato a partir do córtice da espécie da corynanthe pachyceras, uso dos mesmos, medicamento ou produto alimentìcio bem como preparação farmacêutica compreendendo o dito extrato
CA002624703A CA2624703A1 (en) 2005-11-08 2006-11-07 Extracts from the bark of corynanthe species and use thereof as well as medicaments, dietetic food products and pharmaceutical preparations containing said extracts
KR1020087013748A KR101306599B1 (ko) 2005-11-08 2006-11-07 코리난테 종의 수피로부터의 추출물 및 이의 용도, 및 상기추출물을 포함하는 약제, 식이요법 식품 및 약제학적 제제
JP2008539325A JP5435951B2 (ja) 2005-11-08 2006-11-07 コリナンテ種の樹皮からの抽出物、その使用、およびそれを含有する薬剤、ダイエット食品および医薬品
EP06818406A EP1945238A2 (de) 2005-11-08 2006-11-07 Extrakte aus der rinde von corynanthe-arten und deren verwendung sowie diese extrakte enthaltende arzneimittel, diätetische lebensmittel und pharmazeutische zubereitungen

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005053241A DE102005053241A1 (de) 2005-11-08 2005-11-08 Extrakte aus der Rinde von Corynanthe-Arten und deren Verwendung sowie diese Extrakte enthaltende Arzneimittel, diätetische Lebensmittel und pharmazeutische Zubereitungen
DE102005053241.1 2005-11-08

Publications (2)

Publication Number Publication Date
WO2007054269A2 WO2007054269A2 (de) 2007-05-18
WO2007054269A3 true WO2007054269A3 (de) 2007-08-09

Family

ID=37982546

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2006/010663 WO2007054269A2 (de) 2005-11-08 2006-11-07 Extrakte aus der rinde von corynanthe-arten und deren verwendung sowie diese extrakte enthaltende arzneimittel, diätetische lebensmittel und pharmazeutische zubereitungen

Country Status (12)

Country Link
US (1) US20090142428A1 (de)
EP (1) EP1945238A2 (de)
JP (1) JP5435951B2 (de)
KR (1) KR101306599B1 (de)
CN (1) CN101291682A (de)
AU (1) AU2006312678B2 (de)
BR (1) BRPI0618634A2 (de)
CA (1) CA2624703A1 (de)
DE (1) DE102005053241A1 (de)
RU (1) RU2399378C2 (de)
UA (1) UA94434C2 (de)
WO (1) WO2007054269A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101683337B (zh) * 2008-09-27 2011-12-07 复旦大学 柯楠因在制备治疗心肌损伤性心脏病药物中的用途
JP2011125331A (ja) * 2009-11-17 2011-06-30 Taisho Pharmaceutical Co Ltd 魚鱗粉末含有コーティング錠剤
CN102002039B (zh) * 2010-11-12 2012-05-09 天医堂(厦门)生物工程有限公司 一种从育亨宾树皮中提取育亨宾的方法
CN102030747A (zh) * 2010-11-19 2011-04-27 陕西嘉禾植物化工有限责任公司 一种育亨宾碱的制备方法
EP3646871A1 (de) * 2018-10-30 2020-05-06 SEROJAC PME Handels GmbH Behandlung und prävention von vorzeitiger ejakulation

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE758049A (en) * 1970-10-27 1971-04-01 Omnium Chimique Sa Hypotensive, sedative extract of pseudocni - chona africana
EP0086416A2 (de) * 1982-02-12 1983-08-24 Dr. Willmar Schwabe GmbH & Co. Corynanthein-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2112344A1 (en) * 1970-10-27 1972-06-16 Omnium Chimique Sa Hypotensive, sedative extract of pseudocni - chona africana
US6323211B1 (en) * 1996-02-02 2001-11-27 Nitromed, Inc. Compositions and methods for treating sexual dysfunctions
FR2765483B1 (fr) * 1997-07-04 2000-02-04 Philippe Gorny Medicament destine a traiter les dysfonctions erectiles
IT1293539B1 (it) * 1997-07-16 1999-03-01 Sigma Tau Ind Farmaceuti Composizione nutritiva per soggetti in stato di debilitazione causato da stress
ITMI20011237A1 (it) * 2001-06-12 2002-12-12 Enzo Leone Uso della yohimbina per la preparazione di farmaci ad attivita' immunobiologica

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE758049A (en) * 1970-10-27 1971-04-01 Omnium Chimique Sa Hypotensive, sedative extract of pseudocni - chona africana
EP0086416A2 (de) * 1982-02-12 1983-08-24 Dr. Willmar Schwabe GmbH & Co. Corynanthein-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HEIDE KUHLMANN: "Potenzkraft vom Äquator", INTERNET ARTICLE, 22 November 1999 (1999-11-22), XP002435567, Retrieved from the Internet <URL:HTTP://WWW.PHARMAZEUTISCHE-ZEITUNG.DE/FILEADMIN/PZA/1999-47/TITEL.HTM> *
STAERK D ET AL: "Leishmanicidal, antiplasmodial and cytotoxic activity of indole alkaloids from Corynanthe pachyceras", PLANTA MEDICA 2000 GERMANY, vol. 66, no. 6, 2000, pages 531 - 536, XP002435628, ISSN: 0032-0943 *

Also Published As

Publication number Publication date
JP2009514916A (ja) 2009-04-09
RU2008119965A (ru) 2009-12-20
WO2007054269A2 (de) 2007-05-18
BRPI0618634A2 (pt) 2011-09-06
UA94434C2 (ru) 2011-05-10
KR101306599B1 (ko) 2013-09-10
US20090142428A1 (en) 2009-06-04
JP5435951B2 (ja) 2014-03-05
EP1945238A2 (de) 2008-07-23
AU2006312678B2 (en) 2013-03-28
DE102005053241A1 (de) 2007-05-16
RU2399378C2 (ru) 2010-09-20
KR20080071172A (ko) 2008-08-01
CA2624703A1 (en) 2007-05-18
AU2006312678A1 (en) 2007-05-18
CN101291682A (zh) 2008-10-22

Similar Documents

Publication Publication Date Title
WO2006108582A3 (en) Human marker genes and agents for diagnosis, treatment and prophylaxis of cardiovascular disorders and artherosclerosis
WO2007038459A3 (en) Carboxyamine compounds and their use in the treatment of hdac dependent diseases
WO2007061661A3 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
WO2007070052A3 (en) Pharmaceutical compositions and methods for treating or preventing oxalate-related disease
WO2006095029A3 (en) Di-polymer protein conjugates and processes for their preparation
IL228952A0 (en) Medicinal preparations containing ferric-citrate for reducing the level of phosphate in the serum, and their use in the preparation of medicines for the treatment or relief of calcium-related disorders
WO2008076754A3 (en) Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
WO2006047516A3 (en) Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
EP1578421A4 (de) Pharmazeutische präparate für diebehandlung von erkrankungen und pathologischen zuständen der brust
WO2008033464A3 (en) Azetidinone derivatives for the treatment of disorders of the lipid metabolism
WO2005007142A3 (en) Liquid compositions comprising formoterol
MY160153A (en) Process for the preparation of plant extracts for treating skin disorders and enhancing healing of wounds
WO2005082382A8 (en) Formulations of thiomolybdate or thiotungstate compounds and uses thereof
BRPI0418681A (pt) um suplemento dietético para o tratamento e a prevenção de doenças do sistema digestivo e doenças relacionadas ao sistema digestivo e método de produção e administração deste
WO2002047668A3 (de) Neue arzneimittelkompositionen auf der basis von anticholinergika und ciclesonide
WO2008087367A3 (fr) Derives de (phenylthiazolyl)-phenyl-propan-1-one et de (phenyloxazodyl)-phenyl-propan-1-one substitues, preparations et utilisations
WO2007038596A3 (en) Phytosterol nutritional supplements
UA88165C2 (en) Use of trisubstituted benzopyranones
MX2007013301A (es) Agente profilactico/terapeutico para la anormalidades del metabolismo del azucar/lipidos.
WO2007054269A3 (de) Extrakte aus der rinde von corynanthe-arten und deren verwendung sowie diese extrakte enthaltende arzneimittel, diätetische lebensmittel und pharmazeutische zubereitungen
WO2008096203A3 (en) Food extracts containing n-methylnicotinamide for treatment of lipoprotein abnormalities and skin diseases and disorders
WO2005092062A3 (en) Compounds for neurodegenerative disorders
NO20083307L (no) Anvendelse av et ikke-forsapbart ekstrakt fra plantemasse ved behandling av hudaldring
WO2008102017A3 (en) Food comprising polyunsaturated fatty acids for the prevention of chronic diseases
WO2004087181A3 (de) WIRKSTOFFKOMBINATION VON ω3-FETTSÄUREHALTIGEN ÖLEN MIT POLYPHENOLHALTIGEN PFLANZENEXTRAKTEN UND DEREN VERWENDUNG

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200680038827.5

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application
DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2624703

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2006312678

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2008539325

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: MX/a/2008/005921

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 12084745

Country of ref document: US

REEP Request for entry into the european phase

Ref document number: 2006818406

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2006818406

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2006312678

Country of ref document: AU

Date of ref document: 20061107

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2006312678

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 1020087013748

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 2008119965

Country of ref document: RU

WWP Wipo information: published in national office

Ref document number: 2006818406

Country of ref document: EP

ENP Entry into the national phase

Ref document number: PI0618634

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20080508